TCM
TSHA icon

TimesSquare Capital Management’s Taysha Gene Therapies TSHA Stock Holding History

TimesSquare Capital Management’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-665,900
Closed -$4.34M – 204
2022
Q1 		$4.34M Buy
665,900
+6,800
+1% +$50.8K 0.05% 189
2021
Q4 		$7.68M Buy
659,100
+8,500
+1% +$128K 0.07% 189
2021
Q3 		$12.1M Sell
650,600
-32,800
-5% -$623K 0.11% 195
2021
Q2 		$14.5M Buy
683,400
+286,200
+72% +$6.6M 0.12% 189
2021
Q1 		$8.06M Sell
397,200
-27,200
-6% -$736K 0.07% 196
2020
Q4 		$11.3M Buy
424,400
+6,700
+2% +$144K 0.09% 200
2020
Q3 		$9.36M Buy
+417,700
New +$9.83M 0.09% 203

Other funds holding TSHA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return